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Gene Expression of Endocannabinoid System Components  
in Skeletal Muscle and Adipose Tissue of South Asians  
and White Caucasians with Overweight
Kimberly J. Nahon 1,2*, Vasudev Kantae 3*, Roy den Haan1,2, Mark J.W. Hanssen4, Amy C. Harms3,  
Mario van der Stelt5, Thomas Hankemeier3, Ingrid M. Jazet1,2, Wouter D. van Marken Lichtenbelt4,  
Patrick C.N. Rensen1,2 and Mariëtte R. Boon1,2
Objective: The study aimed to investigate whether markers of endocannabinoid signaling differed between 
overweight men of South Asian and white Caucasian descent.
Methods: We included South Asian (n = 10) and white Caucasian (n = 10) men with overweight and pre­
diabetes aged 35 to 50 years. Plasma samples were analyzed for endocannabinoids, their congeners, and 
lipids. In white adipose tissue and skeletal muscle biopsies, mRNA expression of genes involved in the 
endocannabinoid system was assessed using quantitative RT­PCR. Fasting lipid oxidation and glucose oxi­
dation were determined with indirect calorimetry.
Results: Compared with white Caucasians, South Asians had higher levels of plasma 2­linoleoyl glycerol 
(P < 0.01) and N­linoleoylethanolamine (P < 0.05). Interestingly, in skeletal muscle of South Asians, gene ex­
pression of cannabinoid receptors CB1 and CB2 was 10­fold lower (P < 0.001) and that of the endocannabi­
noid degradation enzyme fatty acid amide hydrolase 2 (FAAH2) was 5­fold lower (P < 0.001) compared with 
white Caucasians. Expression of genes involved in the endocannabinoid system in white adipose tissue was 
not different between the two ethnicities. After pooling of both ethnicities, plasma 2­arachidonoylglycerol 
(2­AG) positively correlated with plasma triglycerides (R = 0.77, P < 0.001) and lipid oxidation (R = 0.55, P < 0.05).
Conclusions: Overweight South Asian men have higher plasma 2­linoleoyl glycerol and N­linoleoyle­
thanolamine levels and lower gene expression of CB receptors and the endocannabinoid degradation en­
zyme FAAH2 in skeletal muscle compared with white Caucasians.
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Introduction
The prevalence of obesity and related diseases, such as type 2 
diabetes (T2D), is rapidly increasing worldwide. Particularly 
in South Asians, constituting nearly one‐fourth of the world's 
population (1), an unfavorable metabolic profile consisting 
of obesity, dyslipidemia, and T2D is highly prevalent (2). 
Moreover, South Asians have a higher risk of developing car-
diovascular disease, resulting in high morbidity and mortality 
(3). It is generally thought that the increased susceptibility to 
metabolic disease of South Asians might be due to a disturbed 
energy metabolism (4).
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Obesity
The endocannabinoid system (ECS) is involved in maintaining 
energy balance by impacting on energy intake and expenditure as 
well as lipolysis (5). The ECS is present both centrally and in periph-
eral metabolic tissues, including the liver, pancreas, skeletal muscle, 
white adipose tissue (WAT), and brown adipose tissue (6). In skele-
tal muscle, endocannabinoids reduce glucose uptake and oxidative 
pathways (7,8), thereby reducing energy expenditure. In WAT, endo-
cannabinoids stimulate energy storage by increasing lipogenesis and 
adipogenesis (5,9,10). Thus, endocannabinoid stimulation of skele-
tal muscle and WAT collectively results in a positive energy balance.
The ECS consists of G protein–coupled cannabinoid recep-
tors (i.e., type 1 and type 2 [CB1 and CB2]), the endogenous lipid 
ligands (endocannabinoids), and the enzymatic machinery for their 
synthesis and degradation. Anandamide (AEA) and 2‐arachido-
noylglycerol (2‐AG) are the most studied endocannabinoids and 
are synthesized on demand from their membrane lipids through 
the action of the biosynthetic enzymes N‐acyl‐phosphatidyl‐ 
ethanolamine phospholipase D and diacylglycerol lipase (DAGL), 
respectively. Endocannabinoids are degraded by specific enzymes. 
Fatty acid amide hydrolase (FAAH1 and FAAH2) inactivates 
AEA, and monoglyceride lipase hydrolyzes 2‐AG. Arachidonic 
acid is a precursor molecule and metabolite for endocannabi-
noids. AEA belongs to a family of bioactive N‐acylethanolamines, 
which include N‐linoleoylethanolamine, N‐palmitoylethanolamine, 
N‐oleoylethanolamine, N‐stearoylethanolamine, and N‐docosa-
tetraenylethanolamide. These N‐acylethanolamines arise from the 
same biosynthetic pathway as AEA and are capable of indirectly 
modulating cannabinoid receptor activity by interfering with endo-
cannabinoid metabolism, which is known as an “entourage effect” 
(11). Palmitoylethanolamine and, especially, N‐oleoylethanolamine 
interact with nuclear receptor peroxisome proliferator–activated 
receptor α, stimulate lipolysis in the liver and adipocytes, and act as 
a satiety factor (9,12).
We previously showed that young, healthy, lean South Asian men had 
lower resting energy expenditure (13) and higher circulating endo-
cannabinoid levels compared with matched white Caucasians (14). 
High plasma endocannabinoid levels are associated with obesity 
(15) and T2D (6) and affect peripheral metabolic organs, including 
adipose tissue and skeletal muscle (5). In addition, individuals with 
obesity have reduced gene expression of endocannabinoid degrada-
tion enzymes and CB1 receptor in adipose tissue (16,17). Elevated 
circulating endocannabinoid levels might be a result of decreased 
enzymatic degradation (16). As little is known about ECS in South 
Asian compared with white Caucasian men with overweight and 
prediabetes, we investigated circulating endocannabinoid levels and 
gene expression of CB receptors and enzymes involved in endocan-
nabinoid synthesis and degradation in WAT and skeletal muscle of 
middle‐aged men of South Asian and white Caucasian descent. We 
hypothesized that South Asian men with overweight and prediabe-
tes would have elevated plasma endocannabinoid levels and conse-
quently lower gene expression of CB receptors on peripheral tissues 
compared with Caucasian men with overweight and prediabetes.
Methods
Ethics
Blood and tissue samples were collected as part of a previously 
conducted crossover study to investigate the effect of l‐arginine 
on brown adipose tissue activity and resting energy expenditure 
in South Asian and white Caucasian men with overweight and 
prediabetes (18)  (ClinicalTrials.gov identifier NCT02291458, 
registered November 14, 2014). This study was approved by the 
Ethics Committee of Maastricht University Medical Center and 
the Leiden University Medical Center (LUMC) and undertaken 
in accordance with the principles of the revised Declaration of 
Helsinki. All volunteers provided written informed consent.
Participants and study design
In total, 20 Dutch men with prediabetes and overweight (BMI 
25‐35 kg/m2) of South Asian (n = 10) and white Caucasian (n = 10) 
descent (aged 35‐55 years) were enrolled. South Asians and white 
Caucasians were matched for BMI. This study was conducted at 
the LUMC (the Netherlands) between November 2014 and August 
2015 (18). Subjects underwent medical screening including an oral 
glucose tolerance test to identify individuals with impaired glu-
cose tolerance according to the American Diabetes Association 
2010 (19) and/or World Health Organization criteria. In line with 
the American Diabetes Association criteria (19), prediabetes was 
defined as having either fasting plasma glucose levels between 5.6 
and 6.9 mmol/L or plasma glucose levels 2 hours after an oral 
glucose tolerance test between 7.8 and 11.1 mmol/L. Exclusion 
criteria included the presence of chronic disease, including T2D, 
smoking, and recent body weight change up to 3 months prior to 
the start of the study.
Study procedures
The study procedures were described previously (18). In short, 
subjects were treated for 6 weeks with either l‐arginine (9 g/d) 
(Argimax; Hankintatukku Oy, Karkkila, Finland) or placebo 
supplements (containing 70% microcrystalline cellulose, 29% 
maize starch, and 1% magnesium stearate) in a randomized dou-
ble‐blind crossover design, with a 4‐week washout period. Each 
treatment period was followed by two consecutive study days, 
which consisted of several measurements. During the first study 
day, lipid oxidation and glucose oxidation were determined for 
30 minutes with indirect calorimetry using a face mask (EZcal; 
IDEE, Maastricht Instruments, Maastricht, the Netherlands), 
and subsequently fasted venous blood samples were collected to 
quantify plasma triglycerides (using commercially available en-
zymatic colorimetric kits and an ABX Pentra 400 autoanalyzer; 
Horiba, Montpellier, France) and endocannabinoids (liquid chro-
matography coupled with tandem mass spectrometry [LC‐MS/
MS]) as described previously (14). The next day, fasted WAT (ab-
dominal subcutaneous adipose tissue) and skeletal muscle (vastus 
lateralis) biopsies were collected as described previously (20). The 
tissues were instantly placed in ice‐cold preservation medium 
(BIOPS; OROBOROS Instruments, Innsbruck, Austria) and 
stored at −80°C. Thereafter, body composition was determined 
by means of dual x‐ray absorptiometry (Discovery A; Hologic, 
Bedford, Massachusetts). From one white Caucasian, no dual 
x‐ray absorptiometry scan data were available because of techni-
cal problems. For the purpose of this study, only the fasted blood 
samples and WAT and skeletal muscle biopsies taken after pla-
cebo treatment were analyzed. All samples were taken at the same 
time of the day in all volunteers. Blood samples were obtained 
during the first study day at 11 am after a 4‐hour fast. WAT and 
skeletal muscle biopsies were obtained during the second study 
day at 8 am after an overnight fast.
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Endocannabinoid measurements
Plasma endocannabinoids and their congeners were quanti-
fied with LC‐MS/MS. From the pool of individual study sam-
ples, quality controls were used to generate calibration curves. 
Additionally, all samples were randomized, and each batch in-
cluded calibration samples and an even distribution of quality 
control samples and blanks. The sample extraction procedure 
and method are as described in detail previously (14).
WAT and skeletal muscle gene expression
WAT and skeletal muscle biopsies of South Asians and white 
Caucasians after placebo treatment were analyzed. RNA was 
extracted using TriPure Isolation Reagent (Roche, Molecular 
Biochemicals, Indianapolis, Indiana). Total RNA was reverse‐
transcribed using Promega M1705 reverse transcriptase for re-
verse‐transcription polymerase chain reaction (PCR) (Promega, 
Leiden, the Netherlands) according to the instructions by the 
manufacturer to produce complementary DNA. Gene  expression 
levels of enzymes involved in endocannabinoid synthesis 
(DAGLA and DAGLB, NAPEPLD, and PLA2G4E) and degrada-
tion (MGLL, FAAH1, and FAAH2) and CB receptors (CNR1 and 
CNR2) were determined in a 96‐well PCR plate by real‐time PCR 
(Bio‐Rad CFX96; Bio-Rad, Veenendaal, the Netherlands), using 
gene‐specific primers (Table 1) and iQ SYBR Green Supermix 
(Bio-Rad). For analysis and quantification, Bio‐Rad CFX 
Manager software version 3.1 was used. Gene expression was nor-
malized by using 18S (for WAT) or GAPDH (for skeletal muscle) 
mRNA content and expressed as fold difference compared with 
white Caucasians using the ΔΔCT method.
Statistical analysis
Data were collected and analyzed using SPSS Statistics version 
23.0 (IBM Corp., Armonk, New York). Baseline characteristics 
and differences in plasma endocannabinoid levels between ethnic-
ities were compared using unpaired Student t tests. Furthermore, 
linear regression analysis computed by Pearson correlation was 
used to determine correlations between plasma endocannabinoid 
levels and different metabolic parameters. Regression analysis 
was performed both with and without correction for the effect of 
ethnicity, by respectively including/excluding ethnicity as a co-
variate. P values < 0.05 were considered statistically significant. 
Data are presented as mean ± SEM.
Results
Clinical characteristics
The clinical characteristics of the participants were partly de-
scribed previously (18). In brief, 20 men with overweight and 
prediabetes of South Asian (n = 10) and white Caucasian (n = 10) 
descent were included. Mean age (46.5 ± 2.8 vs. 47.5 ± 2.0 years) 
and BMI (30.1 ± 1.1 vs. 30.7 ± 1.2) were comparable between 
South Asians and white Caucasians, respectively, as were body 
fat percentage (31.0 ± 1.1% vs. 30.1 ± 1.0%), plasma triglyceride 
concentration (1.6 ± 0.2 vs. 1.5 ± 0.2 mmol/L), and fasting glucose 
level (5.6 ± 0.5 vs. 5.7 ± 0.7 mmol/L). Resting energy expenditure 
was lower in South Asians as compared with white Caucasians 
(4.9 ± 0.2 vs. 5.7 ± 0.2 kJ/min, P < 0.05), whereas lipid and glucose 
oxidation did not differ significantly.
South Asians have higher plasma levels of some 
endocannabinoids
First, we studied circulating endocannabinoid levels in both eth-
nicities. Plasma 2‐AG and AEA levels were comparable between 
South Asians and white Caucasians (12.8 ± 1.5 vs. 10.6 ± 1.2 pmol/
mL, Figure 1A, and 1.0 ± 0.1 vs. 0.9 ± 0.1 pmol/mL, Figure 1B, re-
spectively). Plasma arachidonic acid tended to be higher in South 
Asians (18.3 ± 1.1 vs. 14.6 ± 1.6 nmol/mL, P = 0.07; Figure 1C). In 
addition, plasma 2‐linoleoyl glycerol (208 ± 23 vs. 114 ± 17 pmol/
mL, P < 0.01; Figure 1D) and N‐linoleoylethanolamine (3.0 ± 0.2 
vs. 2.2 ± 0.2 pmol/mL, P < 0.05; Figure 1E) were higher in South 
Asians compared with white Caucasians. Plasma 1‐linoleoyl 
glycerol (243 ± 28 vs. 169 ± 30 pmol/mL, P = 0.09; Supporting 
Information Table S1) and N‐docosatetraenylethanolamide 
(6.3 ± 0.4 vs. 5.3 ± 0.4 pmol/mL, P = 0.08; Supporting Information 
Table S1) both tended to be higher in South Asians. No signif-
icant differences were observed for other N‐acylethanolamines 
and mono‐ and di‐acyl glycerols measured.
Circulating endocannabinoid levels correlate with 
plasma triglycerides and lipid oxidation
We next investigated whether circulating endocannabinoid levels 
correlated with metabolic parameters in our study by pooling endo-
cannabinoid levels of the two ethnicities. Plasma 2‐AG levels posi-
tively correlated with plasma triglyceride levels (R = 0.77, P < 0.001; 
Figure 2A) and lipid oxidation (R = 0.55, P < 0.05; Figure 2B). In 
contrast, AEA levels did not correlate with any of these parameters 
(data not shown). To test whether the effects could be attributed to 
ethnicity, we repeated the regression analysis including ethnicity 
as a covariate and found that this did not change the results.
South Asians have lower mRNA expression of 
CB receptors and endocannabinoid degradation 
enzymes in skeletal muscle
Because circulating endocannabinoid levels do not necessarily 
reflect tissue‐specific signaling, we next assessed mRNA expres-
sion of CB receptors and enzymes involved in endocannabinoid 
TABLE 1 Sequences of forward and reverse primers
Gene Forward primer Reverse primer
18S AGGATCCATTGGAGGGCAAGT TCCAACTACGAGCTTTTTAACTGCA
CNR1 GATGTACTTGCCCTGACCATA AACATTCTAGGACTGATTCATCATG
CNR2 AAGATTGGCAGCGTGACTATG CAGGCAGAGGTATCGGTCAA
DAGLA CCATCTTCCTCTTTCTCCT CTCGTGCGGGTTATAGAC
DAGLB GTCTTCCCAGGGTTCTTC TGAGGACGATCAAGTAAC
FAAH1 GGGCCGTCAGCTACACTATGC ATGTTCCATCTGGGCCTCGTC
FAAH2 CGCTAGGCTTTCTCATAGGC CCGAAAGCAGAAGCAATGGTT
GAPDH TTGCAGGAGCGAGATCCCT CACCCATGACGAACATGGG
MGLL TCTTCCTTCTGGGCCACTCCA GGATTGGCAAGAACCAGAGG
NAPEPLD CCCTCTATTCCAAATGTTCT CATCCATTTCCACCATTAC
PLA2G4E GAGCCCACAAACGGATGAAG GTCTGTCTGGCTCAGCATATCA
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synthesis and degradation in WAT and skeletal muscle biopsies of 
South Asian and white Caucasian men.
In WAT, expression levels of all measured genes were not differ-
ent between the two ethnicities (Figure 3A). However, in skeletal 
muscle, the relative expression of the degradation enzyme FAAH2 
(FAAH2) was fivefold lower in South Asians compared with white 
Caucasians (−81%, P < 0.001; Figure 3B). In addition, expression 
of the other degradation enzymes, monoglyceride lipase (MGLL) 
and FAAH1 (FAAH1), tended to be lower in South Asians (−22%, 
P = 0.05 and −18%, P = 0.07, respectively; Figure 3B). Moreover, 
expression of both the CB1 (CNR1) and CB2 (CNR2) receptor 
was approximately 10‐fold lower in South Asians as compared 
with white Caucasians (−93%, P < 0.001 and −90%, P < 0.001; 
Figure 3B). Expression of endocannabinoid synthesis enzymes was 
comparable (Figure 3B) between the two ethnicities.
Discussion
The incidence of obesity and T2D is particularly high in individuals 
of South Asian descent. In the present study, we investigated differ-
ent markers of endocannabinoid signaling in South Asian and white 
Caucasian men with overweight and prediabetes. Here we report 
that plasma 2‐linoleoyl glycerol and N‐linoleoylethanolamine were 
higher in South Asians compared with white Caucasians. In addi-
tion, gene expression of the enzymes involved in endocannabinoid 
degradation as well as CB receptors in skeletal muscle was markedly 
lower in South Asians as compared with white Caucasians. In ad-
dition, plasma 2‐AG correlated positively with plasma triglycerides 
and lipid oxidation.
We observed higher levels of the endocannabinoids 2‐linoleoyl 
glycerol and N‐linoleoylethanolamine in South Asian compared 
with white Caucasian men with overweight and prediabetes. In our 
previous study in healthy lean South Asians and white Caucasians, 
we also observed higher endocannabinoid levels in South Asians; 
however, in that study, other endocannabinoids (i.e., 2‐AG and 
AEA) were higher (14). If  we compare the effect sizes between the 
two different cohorts, we observe that except for N‐palmitoyletha-
nolamide, all effects are in the same direction, albeit that the effect 
sizes differ for most endocannabinoids between the two cohorts. 
Furthermore, there is no clear pattern in the effect size with respect 
to whether it is larger in either the lean cohort or the cohort with 
overweight. This is likely due to the different phenotype of the 
subjects in both cohorts. Of note, circulating endocannabinoid 
Figure 1 Circulating endocannabinoid levels are comparable in South Asian and white Caucasian men. Blood was collected from South Asian (n = 10; black bars) and 
matched white Caucasian (n = 10; white bars) men with overweight and prediabetes. LC-MS/MS was used to measure plasma concentrations of (A) 2-arachidonoylglycerol 
(2-AG), (B) anandamide (AEA), (C) arachidonic acid (AA), (D) 2-linoleoyl glycerol (2-LG),(E) N-linoleoylethanolamine (LEA), concentrations. Values are mean ± SEM. P values 
are based on unpaired t tests. *P < 0.05, **P < 0.01.
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levels in this cohort of men with overweight and prediabetes were 
not significantly higher compared with endocannabinoid levels 
measured in our previous cohort of healthy lean men. Probably, 
the difference in BMI between the two cohorts was insufficiently 
large (average BMI of 22 in lean men vs. 30 in overweight men) to 
observe differences in circulating endocannabinoid levels between 
the two cohorts.
We also found a strong correlation between 2‐AG and plasma tri-
glyceride levels. This correlation was also present in our previous 
cohort of healthy lean South Asian and white Caucasian men (14) 
and is in line with results of Bluher et al. (21). The biological explana-
tion for this correlation is currently unknown. Possibly, it can at least 
partly be explained by the fact that both 2‐AG and triglycerides are 
lipid molecules with common lipid intermediates as precursors (e.g., 
diacylglycerol), resulting in production and secretion into blood of 
2‐AG concomitant with very low‐density lipoprotein triglyceride.
To investigate potential differences in endocannabinoid signaling in 
metabolically active tissues, we examined WAT and skeletal muscle 
biopsies from these men with overweight and prediabetes. We did 
not observe differences in expression of genes involved in endocan-
nabinoid signaling in WAT between the two ethnicities. Interestingly, 
in skeletal muscle, we found that mRNA expression of the endo-
cannabinoid degradation enzymes and CB receptors was lower in 
South Asians as compared with white Caucasians. Possibly, low 
expression of degradation enzymes in skeletal muscle of the South 
Asian men might have contributed to higher local endocannabinoid 
levels within skeletal muscle, thereby possibly inducing CB receptor 
downregulation in this tissue (15). Alternatively, the dietary intake 
between South Asians and white Caucasians may have been differ-
ent, as South Asian diets often contain low n‐3 polyunsaturated 
fatty acids, which have been shown to modulate the expression of 
endocannabinoid synthesis and degradation enzymes and CB recep-
tors (22). Although all subjects used a standardized meal the evening 
before the study day, we cannot exclude that differences in diet might 
have influenced our results. Based on our study, we can thus only 
speculate about the underlying mechanisms, which is an interesting 
subject of future studies. Interestingly, the CB1 receptor regulates 
metabolic processes, including insulin signaling, glucose uptake, and 
fatty acid oxidation in skeletal muscle (7,8). Moreover, overstimula-
tion of CB receptors in skeletal muscle can disrupt insulin signaling 
thereby promoting insulin resistance which could eventually lead to 
development of (pre)diabetes 5. Because South Asians are known 
to have an increased risk for the development of metabolic disease, 
including T2D 2, dysregulation of ECS in skeletal muscle might thus 
contribute to diabetes development in this population.
Our study has several limitations. First, we had a small sample size 
of 10 South Asian and 10 white Caucasian men. Secondly, all indi-
viduals were already metabolically deregulated as they had over-
weight and prediabetes. This may have limited the differences we 
could observe between the two ethnic groups. In addition, we can 
only speculate about the mechanisms underlying the differences 
in ECS signaling between South Asians and white Caucasians. 
Future studies in larger cohorts should investigate whether these 
results also apply to women and lean, non‐prediabetic individuals 
to determine whether these results could be translated to the gen-
eral population. A strength of our study is that we measured both 
circulating endocannabinoids and gene expression of the ECS in 
WAT and skeletal muscle in the same individuals.
Taken together, our data show that plasma 2‐linoleoyl glycerol 
and N‐linoleoylethanolamine were higher in South Asian com-
pared with white Caucasian men with overweight and prediabetes. 
In addition, South Asian individuals had lower gene expression 
of enzymes involved in endocannabinoid degradation and CB 
receptors in skeletal muscle. Although it remains speculative, high 
endocannabinoid levels may deteriorate endocannabinoid signaling 
in metabolic organs, including skeletal muscle, and thereby may 
contribute to the development and/or progression of obesity and 
possibly even T2D, both of which are highly prevalent in South 
Figure 3 Relative gene expression of synthesis and degradation enzymes of endocannabinoids and mRNA expression of cannabinoid (CB) receptors in South Asian and 
white Caucasian men. Abdominal white adipose tissue and skeletal muscle tissue biopsies from the vastus lateralis muscle were taken after an overnight fasting period. 
Gene expression in (A) white adipose tissue and (B) skeletal muscle was determined by quantitative PCR. Gene expression was normalized by using 18S (white adipose 
tissue) or GAPDH (skeletal muscle) mRNA content and expressed as fold change compared with white Caucasians using the ΔΔCT method. Values are presented as 
mean ± SEM. P values are based on an unpaired Student t test. ***P < 0.001. ND, not detectable.
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Asians. Further studies are required to show whether therapeutic 
interventions that target the ECS will improve the metabolic profile 
of these individuals. O
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